Gilead Sciences GILD Earnings Call Transcripts

NASDAQ GILD
$166.53 -2.45 (-1.45%)
At close: Nov 19, 2026 · 4:00 PM EST
26 earnings calls on file for Gilead Sciences, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Gilead Sciences Q3 2026 Earnings Call

Oct 29, 2026 9,031 words · 39 min read
  • Daniel O'DayChairman and Chief Executive Officer
  • Johanna MercierChief Commercial and Corporate Affairs Officer
  • Dietmar BergerChief Medical Officer
  • Andrew DickinsonChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Gilead Sciences Earnings Call Transcripts

Calls26
LatestOct 29, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 26 Gilead Sciences transcripts Register to get access to Gilead Sciences’s earnings call transcripts.

Gilead Sciences Earnings Call Transcripts API

Pull Gilead Sciences's earnings call transcripts - the full call, prepared remarks and the Q&A, speaker by speaker - into your own models and apps with the Business Quant Transcripts API. Add fyq (e.g. Q2 2025) for a given call. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/transcripts?ticker=GILD&api_key=YOUR_API_KEY